Risk factors
Haemonetics (HAE) risk factors
Item 1A of every Haemonetics Corp. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2026 10-K risk factors37 risks1 new10 reworded
A new global ERP rollout could disrupt orders, shipments, customer support, invoicing, payments, and contractual performance.
Filed May 20, 2026 - FY2025 10-K risk factors36 risks
Haemonetics operates across Plasma, Blood Center, and Hospital segments, facing heavy customer concentration and strict FDA regulations. Growth relies on ongoing product innovation, acquisitions like OpSens and Attune Medical, and continuous supply chain execution. Substantial debt, convertible notes, and international operations expose the company to currency, geopolitical, and tax volatility.
Filed May 21, 2025